Market Overview

Goldman Sachs Downgrades Cepheid from Buy to Neutral, Announces PT of $32

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for CPHD

DateFirmActionFromTo
Jul 2015Evercore PartnersDowngradesHoldSell
Jun 2015Craig-HallumUpgradesHoldBuy
Apr 2015JMP SecuritiesMaintainsMarket Outperform

View More Analyst Ratings for CPHD
View the Latest Analyst Ratings

Posted-In: Downgrades Price Target Initiation Analyst Ratings

 

Related Articles (CPHD)

Get Benzinga's Newsletters